THIS SITE IS INTENDED
FOR US CONSUMERS

  • BEVESPI AEROSPHERE is a prescription medication used long-term to treat adults with COPD READ MORE...(chronic obstructive pulmonary disease), including chronic bronchitis, emphysema, or both. SHOW LESS
  • BEVESPI AEROSPHERE is not a rescue inhaler and is not for use to treat sudden COPD symptoms. READ MORE...It is not for use in asthma. SHOW LESS

ABOUT COPD

HOW IS COPD TREATED?

Once you’ve been diagnosed with COPD, you may have many questions running through your mind.

Is there a cure? Are there any medicines that can improve my symptoms?

COPD doesn’t currently have a cure—but there are several options available to help manage it. Your doctor will take your symptoms and other factors into account when recommending the best approach to managing your condition.


Watch to learn more about treatment options for COPD

X


In general, the goals of treatment include:

  • Relieving your symptoms
  • Slowing the progression of your disease
  • Improving your ability to stay active
  • Preventing and treating complications
  • Improving your general health

Some COPD Treatment Options

There are many treatments currently available for COPD. Your doctor will decide what the best treatment option is for you based on the severity of your symptoms. One category of medicine used to treat COPD includes bronchodilators.

BRONCHODILATORS

Bronchodilators are the core of COPD treatment, which makes them likely to be part of any treatment plan. They help relax the muscles around the airways in your lungs, helping to open them up.

They come in short-acting and long-acting forms.

  • Short-acting bronchodilators are used for “rescue” treatment for quick relief of sudden symptoms
  • Long-acting bronchodilators are used for “maintenance” treatment of chronic, long-term symptoms

Long-acting bronchodilators include LABAs (long-acting beta2-adrenergic agonists) and LAMAs (long-acting muscarinic antagonists). BEVESPI AEROSPHERE contains both a LABA and a LAMA. When taken long-term as directed, it helps open your airways and keep them open. It is not a rescue inhaler and not for use to treat sudden COPD symptoms.

Learn more >

OTHER MANAGEMENT MEASURES

Your doctor may recommend other treatments such as vaccines, other medicines, lifestyle changes, and a variety of non-medicinal COPD treatments to help manage your COPD.

icon-checklist

Talk to your doctor openly about your treatment options.

USE THIS DISCUSSION GUIDE TOP

IMPORTANT SAFETY INFORMATION ABOUT BEVESPI AEROSPHERE INCLUDING BOXED WARNING

People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as formoterol fumarate (one of the medicines in BEVESPI AEROSPHERE), have an increased risk of death from asthma problems. It is not known if LABA medicines increase the risk of death in people with COPD. BEVESPI AEROSPHERE is only approved for use in COPD. BEVESPI AEROSPHERE is not approved for use in asthma.

  • Call your healthcare provider if breathing problems worsen over time while using BEVESPI AEROSPHERE
  • Get emergency medical care if your breathing problems worsen quickly or if you use your rescue inhaler, but it does not relieve your breathing problems
  • Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD. Always have a rescue inhaler with you to treat sudden symptoms
  • BEVESPI AEROSPHERE is not for the treatment of asthma. It is not known if BEVESPI AEROSPHERE is safe and effective in people with asthma
  • Do not use BEVESPI AEROSPHERE if you are allergic to glycopyrrolate, formoterol fumarate, or to any of the ingredients in BEVESPI AEROSPHERE
  • Do not use BEVESPI AEROSPHERE more often than prescribed
  • Do not take BEVESPI AEROSPHERE with other medicines that contain a LABA or an anticholinergic for any reason. Tell your healthcare provider about all the medicines you take
  • Tell your healthcare provider about all your medical conditions including heart problems, high blood pressure, seizures, thyroid problems, diabetes, liver problems, glaucoma, prostate or bladder problems, or problems passing urine

BEVESPI AEROSPHERE can cause serious side effects, including:

  • Sudden breathing problems immediately after inhaling your medicine
  • Serious allergic reactions. Call your healthcare provider or get emergency medical care if you get any of the following symptoms of a serious allergic reaction: rash; hives; swelling of the face, mouth and tongue; breathing problems
  • Fast or irregular heartbeat, increased blood pressure, chest pain
  • Tremor or nervousness
  • New or worsened eye problems, including acute narrow-angle glaucoma. Symptoms may include: eye pain or discomfort, nausea or vomiting, blurred vision, seeing halos or bright colors around lights, and red eyes. If you have these symptoms, call your healthcare provider right away before taking another dose
  • New or worsened urinary retention. Symptoms may include difficulty urinating, painful urination, urinating frequently, or urinating in a weak stream or drips. If you have any of these symptoms, stop taking BEVESPI AEROSPHERE and call your healthcare provider right away
  • High blood sugar or low blood potassium

Common side effects of BEVESPI AEROSPHERE include urinary tract infection and cough. Tell your healthcare provider about any side effect that bothers you or that does not go away.

APPROVED USE

BEVESPI AEROSPHERE is a prescription medicine used to treat chronic obstructive pulmonary disease (COPD). COPD includes chronic bronchitis, emphysema, or both. BEVESPI AEROSPHERE is used long term as 2 inhalations, 2 times each day in the morning and in the evening, to improve symptoms of COPD for better breathing. Do not use BEVESPI AEROSPHERE to treat sudden symptoms of COPD; it won't replace a rescue inhaler. BEVESPI AEROSPHERE is not for the treatment of asthma.

Please read full Prescribing Information , including Boxed WARNING, and Medication Guide and Instructions for Use for BEVESPI AEROSPHERE.

IMPORTANT SAFETY INFORMATION ABOUT BEVESPI AEROSPHERE INCLUDING BOXED WARNING

People with asthma who take long-acting beta2-adrenergic agonist (LABA) medicines, such as formoterol fumarate (one of the medicines in BEVESPI AEROSPHERE), have an increased risk of death from asthma problems. It is not known if LABA medicines increase the risk of death in people with COPD.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.1-800-FDA-1088.

USA flagThis site is intended for US Consumers only.

The information on this Web site should not take the place of talking with your doctor or health care professional. If you have any questions about your condition, or if you would like more information about BEVESPI AEROSPHERE or COPD, talk to your doctor or pharmacist. Only you and your doctor can decide if BEVESPI AEROSPHERE is right for you.